Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.50
Bid: 3.30
Ask: 3.70
Change: 0.07 (2.04%)
Spread: 0.40 (12.121%)
Open: 3.55
High: 3.75
Low: 3.50
Prev. Close: 3.43
TERN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tern PLC: Director appointment

31 Mar 2020 07:00

Tern PLC (TERN) Tern PLC: Director appointment 31-March-2020 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


31 March 2020

 

Tern Plc ("Tern" or the "Company")

Director appointment

 

Tern Plc (AIM:TERN), the investment company specialising in the Internet of Things ("IoT"), is pleased to announce the appointment of Matthew Scherba as Investment Director with immediate effect.  Matthew originally joined Tern in December 2019 in a non-Main Board capacity.

Matthew has 25 years of start-up and scale-up experience specialising in working and investing in technology companies across the IoT industry, his experience covers the full company lifecycle development, from start-up to exit, with a focus on strategy and commercial scale across both the private and public sector markets. Prior to joining Tern, he spent almost five years at a UK venture capital investment company dedicated to the IoT arena. During this time, he helped originate, invest and support the development of disruptive technology companies in the UK, Europe and the US, and particularly within artificial intelligence (AI) and machine learning. Additionally, he held board positions on several portfolio companies, and worked with management teams to help develop their strategic, commercial and operational functions.

Al Sisto, CEO of Tern, said:

"With 25 years of experience working with or investing in technology companies, Matthew will be a highly valuable addition to our Board. He has already made a significant contribution since joining our company at the end of 2019 and we look forward to benefitting from his experience at a Board level. As Investment Director, he will help us to expand our support to our portfolio companies, identify commercial businesses and new opportunities in this high growth industry and further develop our investment strategy."

 

 

Matthew Peter Scherba (aged 53)

In accordance with Schedule 2(g) of the AIM Rules, Matthew Scherba holds, or has held in the past five years, the following directorships and partnerships: 

Current

Past five years

Tx3 Solutions Limited

Wearable Technologies LimitedTalepathy Limited

Plancentric Limited

Foodmarble Digestive Health Limited (Ireland)

Plancentric Global Limited

Peafowl Solar Power AB

Foodmarble Digestive Health Limited (UK)

 

InVMA Limited

 

 

Mr Scherba and his family members are beneficially interested in a total of 716,0001 ordinary shares of 0.02p in Tern ("Ordinary Shares"), which is equivalent to 0.25% of the Company's voting rights.

1Mr Scherba is beneficially interested in 325,000 Ordinary Shares and his family members are beneficially interested in the following Ordinary Shares: L Gennard, 325,000 Ordinary Shares, L Scherba, 33,000 Ordinary Shares and S Scherba, 33,000 Ordinary Shares.

 

Enquiries

 

Tern Plc

Al Sisto/Sarah Payne

via Newgate Communications

 

Allenby Capital Limited

(Nomad and Joint broker)

David Worlidge/Alex Brearley/Guy McDougall

 

Tel: 0203 328 5656

 

Whitman Howard

(Joint broker)

Nick Lovering/Christopher Furness

 

Tel: 020 7659 1234

 

Newgate Communications

Elisabeth Cowell/Megan Kovach

 

Tel: 020 3757 6880

 


ISIN:GB00BFPMV798
Category Code:MSCM
TIDM:TERN
LEI Code:2138005F87SODHL9CQ36
Sequence No.:55537
EQS News ID:1011119
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
3rd May 20247:45 amRNSFurther re. Wyld Networks Warrant Exercise Process
30th Apr 20245:00 pmRNSTotal Voting Rights
25th Apr 20247:00 amRNSExercise of warrants held in Wyld Networks
12th Apr 20247:00 amRNSPlacing to raise £420,000
9th Apr 20247:00 amRNSTalking Medicines record revenue bookings in Q1 24
21st Mar 20247:00 amRNSOnline Investor Presentation and Q&A Session
5th Mar 20247:00 amRNSKonektio Administration
7th Feb 20247:00 amRNSDevice Authority Fund Raise
1st Feb 20247:00 amRNSTalking Medicines Fundraise
31st Jan 20245:32 pmRNSTotal Voting Rights
24th Jan 20247:00 amRNSPlacing to raise £400,000
15th Jan 20243:22 pmRNSHolding(s) in Company
28th Dec 20237:00 amRNSCompletion of Tranche One of the DA Fund raise
27th Dec 20237:00 amRNSDevice Authority Fund raise
29th Nov 20237:00 amRNSKonektio update
24th Nov 20237:00 amRNSInvestor Webinar Recording
21st Nov 20237:00 amRNSCompany and Portfolio Update
15th Nov 20237:00 amRNSOnline Investor Presentation and Q&A Session
8th Nov 20237:00 amRNSKonektio update
26th Sep 202312:19 pmRNSResult of GM
31st Aug 20237:00 amRNSNotice of General Meeting
16th Aug 20237:00 amRNSInterim results for the six months to 30 June 2023
10th Aug 20237:00 amRNSBoard and Management Restructuring
4th Aug 20231:33 pmRNSStatement re Share Price Movement
4th Jul 20237:00 amRNSDevice Authority convertible loan note extension
30th Jun 20235:00 pmRNSTotal Voting Rights
29th Jun 202310:09 amRNSResult of AGM and Directorate Change
28th Jun 20237:00 amRNSDevice Authority - Winner of Microsoft Award
12th Jun 202311:35 amRNSFunding facility
31st May 20237:00 amRNSResults for the year ended 31 December 2022
26th May 20237:00 amRNSKonektio Fundraise
23rd May 20237:00 amRNSNotice of Final Results & Investor Q&A Session
25th Apr 20237:00 amRNSKonektio Fundraise
18th Apr 20237:00 amRNSPortfolio Update and Investor Presentation
31st Mar 20239:00 amRNSWyld Networks Q4 2022 Interim Report
13th Mar 20237:45 amRNSWyld Networks SEK 9.2 million Purchase Order
13th Mar 20237:00 amRNSStatement regarding Silicon Valley Bank
10th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20238:49 amRNSInvestor webinar recording
7th Feb 20237:00 amRNSOnline Investor Presentation and Q&A Session
2nd Feb 202311:08 amRNSProposed Wyld Networks Directorate Change
25th Jan 20237:00 amRNSPortfolio Update & Investor Presentation
12th Jan 20237:30 amRNSWyld Networks SEK 12.6 million Purchase Order
30th Dec 20221:00 pmRNSTotal Voting Rights
22nd Dec 20222:31 pmRNSFurther re. Wyld Networks Warrant Exercise
22nd Dec 20227:00 amRNSKonektio Secondment
21st Dec 20223:14 pmRNSHolding(s) in Company
13th Dec 20227:00 amRNSWyld Networks Warrant Exercise
8th Dec 20227:45 amRNSLaunch of Wyld Networks Satellite IoT Network
8th Dec 20227:00 amRNSSubscription to raise £1.5 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.